Skip to content

Clinical trials

Completed Pancreatic Neoplasms trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Status: Completed Country / region: Norway Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20112
20122
20141
20181
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Active Biotech AB1
Bayer1
Eli Lilly and Company1
Helse Stavanger HF1
Immunovia, Inc.1
Karolinska Institutet1
MedImmune LLC1
Pfizer1
Sanofi1
Targovax ASA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms10
Carcinoma2
Adenoma1
Biliary Tract Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Liver Neoplasms1
Neoplasms1
Neoplastic Cells, Circulating1
Neuroendocrine Tumors1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.